Huntington National Bank’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6 | Sell |
1
-39
| -98% | -$234 | ﹤0.01% | 3824 |
|
2025
Q1 | $326 | Sell |
40
-296
| -88% | -$2.41K | ﹤0.01% | 2538 |
|
2024
Q4 | $3.16K | Buy |
336
+120
| +56% | +$1.13K | ﹤0.01% | 2134 |
|
2024
Q3 | $2.31K | Hold |
216
| – | – | ﹤0.01% | 2207 |
|
2024
Q2 | $2.14K | Buy |
216
+138
| +177% | +$1.37K | ﹤0.01% | 2145 |
|
2024
Q1 | $919 | Buy |
78
+20
| +34% | +$236 | ﹤0.01% | 2294 |
|
2023
Q4 | $823 | Buy |
58
+57
| +5,700% | +$809 | ﹤0.01% | 2246 |
|
2023
Q3 | $12 | Hold |
1
| – | – | ﹤0.01% | 3358 |
|
2023
Q2 | $13 | Hold |
1
| – | – | ﹤0.01% | 3308 |
|
2023
Q1 | $11 | Hold |
1
| – | – | ﹤0.01% | 3203 |
|
2022
Q4 | $12 | Hold |
1
| – | – | ﹤0.01% | 3043 |
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2192 |
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2207 |
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2179 |
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2139 |
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1896 |
|
2021
Q2 | $0 | Sell |
1
-737
| -100% | – | ﹤0.01% | 1816 |
|
2021
Q1 | $7K | Sell |
738
-38
| -5% | -$360 | ﹤0.01% | 1402 |
|
2020
Q4 | $18K | Sell |
776
-64
| -8% | -$1.49K | ﹤0.01% | 1152 |
|
2020
Q3 | $12K | Buy |
840
+839
| +83,900% | +$12K | ﹤0.01% | 1180 |
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1616 |
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1675 |
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1760 |
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1641 |
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1685 |
|